Abstract
BackgroundSelecting patients with peritoneal metastases from colorectal cancer (CRCPM) who might benefit from cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is challenging. Computed tomography generally underestimates the peritoneal tumor load. Diagnostic laparoscopy is often used to determine whether patients are amenable for surgery. Magnetic resonance imaging (MRI) has shown to be accurate in predicting completeness of CRS. The aim of this study is to determine whether MRI can effectively reduce the need for surgical staging.MethodsThe study is designed as a multicenter randomized controlled trial (RCT) of colorectal cancer patients who are deemed eligible for CRS-HIPEC after conventional CT staging. Patients are randomly assigned to either MRI based staging (arm A) or to standard surgical staging with or without laparoscopy (arm B). In arm A, MRI assessment will determine whether patients are eligible for CRS-HIPEC. In borderline cases, an additional diagnostic laparoscopy is advised. The primary outcome is the number of unnecessary surgical procedures in both arms defined as: all surgeries in patients with definitely inoperable disease (PCI>24) or explorative surgeries in patients with limited disease (PCI
Original language | English |
---|---|
Article number | 464 |
Number of pages | 8 |
Journal | BMC Cancer |
Volume | 21 |
Issue number | 1 |
DOIs | |
Publication status | Published - 26 Apr 2021 |
Keywords
- Colorectal peritoneal metastases
- CRS-HIPEC
- Surgical staging
- MRI
- RCT
- HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
- CYTOREDUCTIVE SURGERY
- COMPUTED-TOMOGRAPHY
- LAPAROSCOPY
- CARCINOMATOSIS
- MANAGEMENT
- INDEX